Clinical Trial Update: Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the safety of Tobramycin Inhalation Powder (TIP) to Tobramycin Inhalation Solution in cystic fibrosis patients; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Tobramycin Inhalation Powder (tobramycin inhalation powder)
• Tobramycin Inhalation Solution (TOBI) (tobramycin inhalation solution)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2012-07-24